HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dae-Kee Kim Selected Research

Therapeutic Uses

11/2015Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.
11/2013Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dae-Kee Kim Research Topics

Disease

19Neoplasms (Cancer)
06/2023 - 01/2003
11Breast Neoplasms (Breast Cancer)
11/2015 - 05/2004
10Fibrosis (Cirrhosis)
01/2023 - 07/2011
6Neoplasm Metastasis (Metastasis)
06/2023 - 10/2011
3Hyperplasia
05/2013 - 04/2010
3Stomach Neoplasms (Stomach Cancer)
12/2012 - 10/2002
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2023 - 01/2016
2Non-alcoholic Fatty Liver Disease
01/2023 - 01/2022
2Inflammation (Inflammations)
01/2022 - 11/2007
2Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2015 - 07/2011
2Hepatocellular Carcinoma (Hepatoma)
12/2008 - 04/2004
2Erectile Dysfunction
09/2007 - 08/2007
1Adenocarcinoma
06/2023
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2023
1Fatty Liver
01/2023
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2022
1Pathologic Constriction (Stenosis)
07/2017
1Leukemia
02/2016
1Ureteral Obstruction
05/2015
1Melanoma (Melanoma, Malignant)
11/2013
1Experimental Melanoma
11/2013
1Necrosis
03/2013
1Penile Induration (Peyronie's Disease)
05/2009
1Pulmonary Hypertension
02/2009
1Hypoxia (Hypoxemia)
02/2009
1Right Ventricular Hypertrophy
02/2009
1Vascular Remodeling
02/2009
1Pulmonary Arterial Hypertension
02/2009
1Prostatic Neoplasms (Prostate Cancer)
12/2008
1Encephalomyelitis (Myeloencephalitis)
11/2007
1Paralysis (Palsy)
11/2007

Drug/Important Bio-Agent (IBA)

10Phosphotransferases (Kinase)IBA
06/2023 - 05/2009
9vactosertibIBA
06/2023 - 11/2013
8Transforming Growth Factors (Transforming Growth Factor)IBA
06/2023 - 02/2009
7Activin Receptors (Activin Receptor)IBA
11/2013 - 12/2008
7Histone Deacetylase InhibitorsIBA
05/2012 - 05/2004
6Histone Deacetylases (Histone Deacetylase)IBA
01/2012 - 12/2003
5CollagenIBA
06/2023 - 07/2017
43- ((5- (6- methylpyridin- 2- yl)- 4- (quinoxalin- 6- yl)- 1H- imidazol- 2- yl)methyl)benzamideIBA
08/2014 - 12/2008
43- (4- dimethylaminophenyl)- N- hydroxy- 2- propenamideIBA
05/2012 - 05/2006
4Estrogen ReceptorsIBA
05/2012 - 05/2004
43- ((4- (6- methylpyridin- 2- yl)- 5- (quinolin- 6- yl)- 1H- imidazol- 2- yl)methyl)benzamideIBA
09/2011 - 02/2009
4Transforming Growth Factor beta (TGF-beta)IBA
07/2011 - 11/2007
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 01/2022
2Therapeutic UsesIBA
11/2015 - 11/2013
2CyclinsIBA
01/2012 - 08/2004
2benzonitrileIBA
11/2011 - 10/2011
2Transforming Growth Factor beta1 (TGF beta 1)IBA
05/2009 - 11/2007
2Transforming Growth Factor-beta Type I ReceptorIBA
05/2009 - 12/2008
2SK-7068IBA
01/2008 - 08/2004
2Histones (Histone)IBA
05/2006 - 04/2004
2HC toxinIBA
06/2004 - 05/2004
2trichostatin A (A 300)IBA
06/2004 - 05/2004
2Complementary DNA (cDNA)IBA
01/2003 - 10/2002
2AntigensIBA
01/2003 - 10/2002
1Fibronectins (Fibronectin)IBA
06/2023
1GemcitabineFDA Link
06/2023
1Drug CombinationsIBA
01/2023
1AMP-Activated Protein KinasesIBA
01/2023
1CurcuminIBA
01/2023
1AcidsIBA
01/2022
1EstersIBA
01/2022
1Tyrosine Kinase InhibitorsIBA
02/2016
1Paclitaxel (Taxol)FDA LinkGeneric
11/2015
1Bleomycin (Blenoxane)FDA LinkGeneric
05/2015
1Carbon Tetrachloride (Tetrachloromethane)IBA
05/2015
1LY-2157299IBA
11/2013
1UbiquitinIBA
11/2013
1Smad4 ProteinIBA
11/2013
1A 62176IBA
12/2012
1Cyclin D1IBA
12/2012
1Estrogen Receptor Modulators (Antiestrogen)IBA
05/2012
1EnzymesIBA
01/2012
1Apoptosis Regulatory ProteinsIBA
01/2012
1Thymidylate SynthaseIBA
01/2012
1Hormones (Hormone)IBA
01/2012
13- ((4- ((1,2,4)triazolo(1,5- a)pyridin- 6- yl)- 5- (6- methylpyridin- 2- yl)- 1H- imidazol- 2- yl)methylamino)benzonitrileIBA
11/2011
13- ((5- ((1,2,4)triazolo(1,5- a)pyridin- 6- yl)- 4- (6- methylpyridin- 2- yl)thiazol- 2- ylamino)methyl)benzonitrileIBA
10/2011
1Environmental Pollutants (Pollutants, Environmental)IBA
07/2011
1Proteins (Proteins, Gene)FDA Link
07/2011
1CytokinesIBA
07/2011
1OzoneIBA
07/2011
1Plasminogen Activator Inhibitor 1IBA
07/2011
1MonocrotalineIBA
02/2009
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
02/2009
1Aurora Kinase AIBA
01/2008
1LAQ824IBA
01/2008
1PiperazineIBA
09/2007
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
09/2007
12- (5- (4- (2- hydroxyethyl)piperazin- 1- ylsulfonyl)- 2- n- propoxyphenyl)- 5- ethyl- 7- n- propyl- 3,5- dihydro- 4H- pyrrolo(3,2- d)pyrimidin- 4- one dihydrochlorideIBA
09/2007
1Phosphodiesterase 5 InhibitorsIBA
08/2007
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
08/2007
1Sildenafil Citrate (Viagra)FDA Link
08/2007
1Cyclin-Dependent Kinases (cdk Proteins)IBA
08/2004
1SK-7041IBA
08/2004

Therapy/Procedure

4Stents
07/2017 - 04/2010
4Therapeutics
11/2015 - 05/2012
2Ligation
01/2016 - 05/2015
1Drug Therapy (Chemotherapy)
11/2015
1Intraperitoneal Injections
07/2011